Lesinurad monotherapy in gout patients intolerant to a xanthine oxidase inhibitor: a 6 month phase 3 clinical trial and extension study.

Files in this item

There are no files associated with this item.

Find Full text

This item appears in the following Collection(s)

Share

Search ResearchSpace


Browse

Statistics